Nanotechnology for Healthcare Market Insights, Global Outlook and Forecast 2022-2028
Nanotechnology for Healthcare Market Insights, Global Outlook and Forecast 2022-2028
The Nanotechnology for Healthcare study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.
The latest research study released by Market IntelliX evaluates market size and forecasts of Nanotechnology for Healthcare in Global, including the following market information:
Global Nanotechnology for Healthcare Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Nanotechnology for Healthcare market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nanomedicine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nanotechnology for Healthcare include Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co and Biogen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Nanotechnology for Healthcare companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Nanotechnology for Healthcare Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Nanotechnology for Healthcare Market Segment Percentages, by Type, 2021 (%)
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Global Nanotechnology for Healthcare Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Nanotechnology for Healthcare Market Segment Percentages, by Application, 2021 (%)
Anticancer
CNS Product
Anti-infective
Other
Global Nanotechnology for Healthcare Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Nanotechnology for Healthcare Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nanotechnology for Healthcare revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Nanotechnology for Healthcare revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Nanotechnology for Healthcare Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nanotechnology for Healthcare Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nanotechnology for Healthcare Overall Market Size
2.1 Global Nanotechnology for Healthcare Market Size: 2021 VS 2028
2.2 Global Nanotechnology for Healthcare Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nanotechnology for Healthcare Players in Global Market
3.2 Top Global Nanotechnology for Healthcare Companies Ranked by Revenue
3.3 Global Nanotechnology for Healthcare Revenue by Companies
3.4 Top 3 and Top 5 Nanotechnology for Healthcare Companies in Global Market, by Revenue in 2021
3.5 Global Companies Nanotechnology for Healthcare Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nanotechnology for Healthcare Players in Global Market
3.6.1 List of Global Tier 1 Nanotechnology for Healthcare Companies
3.6.2 List of Global Tier 2 and Tier 3 Nanotechnology for Healthcare Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Nanotechnology for Healthcare Market Size Markets, 2021 & 2028
4.1.2 Nanomedicine
4.1.3 Nano Medical Devices
4.1.4 Nano Diagnosis
4.1.5 Other
4.2 By Type - Global Nanotechnology for Healthcare Revenue & Forecasts
4.2.1 By Type - Global Nanotechnology for Healthcare Revenue, 2017-2022
4.2.2 By Type - Global Nanotechnology for Healthcare Revenue, 2023-2028
4.2.3 By Type - Global Nanotechnology for Healthcare Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nanotechnology for Healthcare Market Size, 2021 & 2028
5.1.2 Anticancer
5.1.3 CNS Product
5.1.4 Anti-infective
5.1.5 Other
5.2 By Application - Global Nanotechnology for Healthcare Revenue & Forecasts
5.2.1 By Application - Global Nanotechnology for Healthcare Revenue, 2017-2022
5.2.2 By Application - Global Nanotechnology for Healthcare Revenue, 2023-2028
5.2.3 By Application - Global Nanotechnology for Healthcare Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Nanotechnology for Healthcare Market Size, 2021 & 2028
6.2 By Region - Global Nanotechnology for Healthcare Revenue & Forecasts
6.2.1 By Region - Global Nanotechnology for Healthcare Revenue, 2017-2022
6.2.2 By Region - Global Nanotechnology for Healthcare Revenue, 2023-2028
6.2.3 By Region - Global Nanotechnology for Healthcare Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Nanotechnology for Healthcare Revenue, 2017-2028
6.3.2 US Nanotechnology for Healthcare Market Size, 2017-2028
6.3.3 Canada Nanotechnology for Healthcare Market Size, 2017-2028
6.3.4 Mexico Nanotechnology for Healthcare Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Nanotechnology for Healthcare Revenue, 2017-2028
6.4.2 Germany Nanotechnology for Healthcare Market Size, 2017-2028
6.4.3 France Nanotechnology for Healthcare Market Size, 2017-2028
6.4.4 U.K. Nanotechnology for Healthcare Market Size, 2017-2028
6.4.5 Italy Nanotechnology for Healthcare Market Size, 2017-2028
6.4.6 Russia Nanotechnology for Healthcare Market Size, 2017-2028
6.4.7 Nordic Countries Nanotechnology for Healthcare Market Size, 2017-2028
6.4.8 Benelux Nanotechnology for Healthcare Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Nanotechnology for Healthcare Revenue, 2017-2028
6.5.2 China Nanotechnology for Healthcare Market Size, 2017-2028
6.5.3 Japan Nanotechnology for Healthcare Market Size, 2017-2028
6.5.4 South Korea Nanotechnology for Healthcare Market Size, 2017-2028
6.5.5 Southeast Asia Nanotechnology for Healthcare Market Size, 2017-2028
6.5.6 India Nanotechnology for Healthcare Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Nanotechnology for Healthcare Revenue, 2017-2028
6.6.2 Brazil Nanotechnology for Healthcare Market Size, 2017-2028
6.6.3 Argentina Nanotechnology for Healthcare Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nanotechnology for Healthcare Revenue, 2017-2028
6.7.2 Turkey Nanotechnology for Healthcare Market Size, 2017-2028
6.7.3 Israel Nanotechnology for Healthcare Market Size, 2017-2028
6.7.4 Saudi Arabia Nanotechnology for Healthcare Market Size, 2017-2028
6.7.5 UAE Nanotechnology for Healthcare Market Size, 2017-2028
7 Players Profiles
7.1 Amgen
7.1.1 Amgen Corporate Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Nanotechnology for Healthcare Major Product Offerings
7.1.4 Amgen Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.1.5 Amgen Key News
7.2 Teva Pharmaceuticals
7.2.1 Teva Pharmaceuticals Corporate Summary
7.2.2 Teva Pharmaceuticals Business Overview
7.2.3 Teva Pharmaceuticals Nanotechnology for Healthcare Major Product Offerings
7.2.4 Teva Pharmaceuticals Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.2.5 Teva Pharmaceuticals Key News
7.3 Abbott
7.3.1 Abbott Corporate Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Nanotechnology for Healthcare Major Product Offerings
7.3.4 Abbott Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.3.5 Abbott Key News
7.4 UCB
7.4.1 UCB Corporate Summary
7.4.2 UCB Business Overview
7.4.3 UCB Nanotechnology for Healthcare Major Product Offerings
7.4.4 UCB Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.4.5 UCB Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Nanotechnology for Healthcare Major Product Offerings
7.5.4 Roche Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.5.5 Roche Key News
7.6 Celgene
7.6.1 Celgene Corporate Summary
7.6.2 Celgene Business Overview
7.6.3 Celgene Nanotechnology for Healthcare Major Product Offerings
7.6.4 Celgene Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.6.5 Celgene Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Nanotechnology for Healthcare Major Product Offerings
7.7.4 Sanofi Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.7.5 Sanofi Key News
7.8 Merck & Co
7.8.1 Merck & Co Corporate Summary
7.8.2 Merck & Co Business Overview
7.8.3 Merck & Co Nanotechnology for Healthcare Major Product Offerings
7.8.4 Merck & Co Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.8.5 Merck & Co Key News
7.9 Biogen
7.9.1 Biogen Corporate Summary
7.9.2 Biogen Business Overview
7.9.3 Biogen Nanotechnology for Healthcare Major Product Offerings
7.9.4 Biogen Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.9.5 Biogen Key News
7.10 Stryker
7.10.1 Stryker Corporate Summary
7.10.2 Stryker Business Overview
7.10.3 Stryker Nanotechnology for Healthcare Major Product Offerings
7.10.4 Stryker Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.10.5 Stryker Key News
7.11 Gilead Sciences
7.11.1 Gilead Sciences Corporate Summary
7.11.2 Gilead Sciences Business Overview
7.11.3 Gilead Sciences Nanotechnology for Healthcare Major Product Offerings
7.11.4 Gilead Sciences Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.11.5 Gilead Sciences Key News
7.12 Pfizer
7.12.1 Pfizer Corporate Summary
7.12.2 Pfizer Business Overview
7.12.3 Pfizer Nanotechnology for Healthcare Major Product Offerings
7.12.4 Pfizer Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.12.5 Pfizer Key News
7.13 3M Company
7.13.1 3M Company Corporate Summary
7.13.2 3M Company Business Overview
7.13.3 3M Company Nanotechnology for Healthcare Major Product Offerings
7.13.4 3M Company Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.13.5 3M Company Key News
7.14 Johnson & Johnson
7.14.1 Johnson & Johnson Corporate Summary
7.14.2 Johnson & Johnson Business Overview
7.14.3 Johnson & Johnson Nanotechnology for Healthcare Major Product Offerings
7.14.4 Johnson & Johnson Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.14.5 Johnson & Johnson Key News
7.15 Smith & Nephew
7.15.1 Smith & Nephew Corporate Summary
7.15.2 Smith & Nephew Business Overview
7.15.3 Smith & Nephew Nanotechnology for Healthcare Major Product Offerings
7.15.4 Smith & Nephew Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.15.5 Smith & Nephew Key News
7.16 Leadiant Biosciences
7.16.1 Leadiant Biosciences Corporate Summary
7.16.2 Leadiant Biosciences Business Overview
7.16.3 Leadiant Biosciences Nanotechnology for Healthcare Major Product Offerings
7.16.4 Leadiant Biosciences Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.16.5 Leadiant Biosciences Key News
7.17 Kyowa Hakko Kirin
7.17.1 Kyowa Hakko Kirin Corporate Summary
7.17.2 Kyowa Hakko Kirin Business Overview
7.17.3 Kyowa Hakko Kirin Nanotechnology for Healthcare Major Product Offerings
7.17.4 Kyowa Hakko Kirin Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.17.5 Kyowa Hakko Kirin Key News
7.18 Shire
7.18.1 Shire Corporate Summary
7.18.2 Shire Business Overview
7.18.3 Shire Nanotechnology for Healthcare Major Product Offerings
7.18.4 Shire Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.18.5 Shire Key News
7.19 Ipsen
7.19.1 Ipsen Corporate Summary
7.19.2 Ipsen Business Overview
7.19.3 Ipsen Nanotechnology for Healthcare Major Product Offerings
7.19.4 Ipsen Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.19.5 Ipsen Key News
7.20 Endo International
7.20.1 Endo International Corporate Summary
7.20.2 Endo International Business Overview
7.20.3 Endo International Nanotechnology for Healthcare Major Product Offerings
7.20.4 Endo International Nanotechnology for Healthcare Revenue in Global Market (2017-2022)
7.20.5 Endo International Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Nanotechnology for Healthcare Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|